| Financial Year |
March 31 2023 |
| Monetary Funds |
347,102,006.25 |
| Held-for-trading Financial Assets |
20,006,333.33 |
| Notes Receivable |
-- |
| Accounts Receivable |
46,723,175.11 |
| Advances to Suppliers |
65,602,230.42 |
| Other Receivables |
6,434,771.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,254,489.19 |
| Total Current Assets |
496,816,369.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
71,274,472.24 |
| Investment Properties |
9,053,680.44 |
| Fixed Assetes |
11,645,115.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,035,123.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
97,471.26 |
| Deferred Income Tax Assets |
1,397,471.32 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
100,200,655.15 |
| Total Assets |
597,017,024.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,385,200.00 |
| Accounts Payable |
27,199,963.27 |
| Accounts Received In Advance |
523,346.25 |
| Employee Compensation Payable |
6,166,199.12 |
| Taxes Payable |
343,241.65 |
| Interest Payable |
17,497.33 |
| Dividend Payable |
-- |
| Other payables |
3,445,333.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
691,711.46 |
| Other Current Liabilities |
1,280,999.79 |
| Sub-Total of Current Liabilities |
91,377,575.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,260,956.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,622,839.31 |
| Total Liabilities |
96,000,414.40 |
| Paid-In Capital(Or Share Stock) |
197,600,000.00 |
| Capital Surplus |
21,273,937.41 |
| Surplus Reserve |
35,353,568.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
240,308,841.50 |
| Minority Stockholder's Interest |
6,733,349.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
494,283,260.50 |
| Owner's Equity（Stockholder's Equity） |
501,016,610.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
597,017,024.60 |
